Elsovaptan

It's only fair to share...

Elsovaptan

CAS 2296801-25-5

MFC19H20ClN5O2 MW385.8 g/mol

[(3S)-7-chloro-3-methyl-2,3-dihydro-1,4-benzoxazin-4-yl]-(6-pyrimidin-2-yl-2,6-diazaspiro[3.3]heptan-2-yl)methanone

[(3S)-7-chloro-3-methyl-2,3-dihydro-4H-1,4-benzoxazin-4-yl][6-(pyrimidin-2-yl)-2,6-diazaspiro[3.3]heptan-2-yl]methanone
vasopressin receptor antagonist, Alzheimer disease, T206306, Y2Z74WGU3J

Elsovaptan is a selective vasopressin receptor antagonist. It is primarily used in scientific research to study the modulation of vasopressin action, particularly in the context of neurodegenerative conditions like Alzheimer’s disease

Primary Mechanism: Blocks the binding of vasopressin to its receptors, which typically disrupts fluid volume regulation and can lead to vasodilation.

Research Applications

Currently, Elsovaptan is designated as a research-use-only compound and is not approved for human therapeutic or veterinary use.

Its study is often linked to research on:

Neurodegenerative Diseases: Investigating the role of the vasopressin system in the progression of Alzheimer’s disease.
Fluid Regulation: Understanding how antagonizing vasopressin affects vascular resistance and blood pressure.

The compound has been listed in recent International Nonproprietary Names (INN) proposals by the World Health Organization (WHO) for pharmaceutical substances, indicating it is an active subject of pharmacological study

ADVERTISEMENT

ANAX LABORATORIES

WEBSITE https://www.anaxlab.com/

Discovery Solutions, Supporting the chemistry needs of clients in the Medical, Analytical and Bio Sciences

Development Solutions, Developing from Lab scale to PR&D, Kilo Scale-ups and Commercial Scales

SEE MORE………Integrated Solutions, Manufacturing Solutions, Products,
Can’t Find? Let’s Connect